Rosen Urges Department of Health and Human Services to Investigate, Help Bring Lower Cost Life-Saving Cancer Drug to Patients
June 26, 2024
June 26, 2024
WASHINGTON, June 26 -- Sen. Jacky Rosen, D-Nevada, issued the following news release:
Today, U.S. Senator Jacky Rosen (D-NV) sent a letter urging Secretary of Health and Human Services Xavier Becerra to investigate and address why a low-cost, generic, life-saving cancer drug has not been made available to patients. Despite the existence of low-cost abiraterone, a generic oral drug used as part of prostate cancer treatment, the average cost of medication to treat this form of cancer . . .
Today, U.S. Senator Jacky Rosen (D-NV) sent a letter urging Secretary of Health and Human Services Xavier Becerra to investigate and address why a low-cost, generic, life-saving cancer drug has not been made available to patients. Despite the existence of low-cost abiraterone, a generic oral drug used as part of prostate cancer treatment, the average cost of medication to treat this form of cancer . . .